Ascitis as a unique microenvironment of tumors in ovarian cancer: interaction with prognosis and chemoresistance

The severe heterogeneity of ovarian carcinomas on the molecular genetic level is associated with the absence of specific markers of chemoresistance. At the same time, ascites is an attractive biomarker detection fluid because it is easily obtained. The review is dedicated to the latest advances in t...

Full description

Bibliographic Details
Published in:	Успехи молекулярной онкологии
Main Authors:	A. B. Villert, L. A. Kolomiets, N. V. Yunusova
Format:	Article
Language:	Russian
Published:	ABV-press 2019-07-01
Subjects:	ovarian cancer ascites prognosis chemoresistance
Online Access:	https://umo.abvpress.ru/jour/article/view/214

Similar Items

Ascites as a subject of studies in ovarian cancer
by: A. B. Villert, et al.
Published: (2019-02-01)

Molecular characteristics and tumorigenicity of ascites‐derived tumor cells: mitochondrial oxidative phosphorylation as a novel therapy target in ovarian cancer
by: Yi Ding, et al.
Published: (2021-12-01)

Adipocyte pyroptosis occurs in omental tumor microenvironment and is associated with chemoresistance of ovarian cancer
by: Chang-Ni Lin, et al.
Published: (2024-06-01)

Mechanisms Involved in Chemoresistance in Ovarian Cancer
by: Kar-San Ling, et al.
Published: (2005-09-01)

Associations of novel serum lipid index with epithelial ovarian cancer chemoresistance and prognosis
by: Yuan Li, et al.
Published: (2023-02-01)

Getting to know ovarian cancer ascites: opportunities for targeted therapy- based translational research
by: Nuzhat eAhmed, et al.
Published: (2013-09-01)

The Role of Tumor-Associated Macrophages in the Progression and Chemoresistance of Ovarian Cancer
by: Marek Nowak, et al.
Published: (2020-05-01)

The effects of REG4 expression on chemoresistance of ovarian cancer
by: Li-Wei Xiang, et al.
Published: (2022-10-01)

Chemotherapy‐induced release of ADAM17 bearing EV as a potential resistance mechanism in ovarian cancer
by: Gerrit Hugendieck, et al.
Published: (2023-07-01)

Harnessing ovarian cancer ascites for translational science: models, biomarkers, and therapeutics
by: Samrita Dogra, et al.
Published: (2025-10-01)

THE IMPACT OF RAD6 EXPRESSION ON CHEMORESISTANT OVARIAN CANCER: A SYSTEMATIC REVIEW
by: Leo Vernadesly, et al.
Published: (2025-01-01)

Platinum-induced upregulation of ITGA6 promotes chemoresistance and spreading in ovarian cancer
by: Alice Gambelli, et al.
Published: (2024-04-01)

Equol induces apoptosis in chemoresistant ovarian cancer cells via external pathway
by: Xue-Mei Gong, et al.
Published: (2015-12-01)

Overexpression of PDK4 is associated with cell proliferation, drug resistance and poor prognosis in ovarian cancer
by: Wang J, et al.
Published: (2018-12-01)

Exosomal Plasma Gelsolin Is an Immunosuppressive Mediator in the Ovarian Tumor Microenvironment and a Determinant of Chemoresistance
by: Toshimichi Onuma, et al.
Published: (2022-10-01)

EPLIN Expression in Gastric Cancer and Impact on Prognosis and Chemoresistance
by: Wenjing Gong, et al.
Published: (2021-04-01)

Parameters of the glutathione system and thioredoxin in blood plasma and ascites and GSTP1 Ile105Val gene polymorphism as factors of resistance to platinum-containing chemotherapy in ovarian cancer patients
by: D. R. Dolgova, et al.
Published: (2021-01-01)

Impact of Obesity and Lysosomal Dysfunction on Chemoresistance in Ovarian Cancer
by: Boyun Kim, et al.
Published: (2024-03-01)

SPL-108 mitigates metastasis and chemoresistance in tubo-ovarian carcinoma
by: Olivia D. Lara, et al.
Published: (2025-01-01)

Patient‐derived acellular ascites fluid affects drug responses in ovarian cancer cell lines through the activation of key signalling pathways
by: Katharina Bischof, et al.
Published: (2025-01-01)

Association of common glutathione transferase polymorphisms with ovarian cancer risk and chemoresistance
by: Simić Petar, et al.
Published: (2024-01-01)

Prediction of Chemoresistance—How Preclinical Data Could Help to Modify Therapeutic Strategy in High-Grade Serous Ovarian Cancer
by: Jacek Wilczyński, et al.
Published: (2023-12-01)

Ovarian cancer ascites confers platinum chemoresistance to ovarian cancer cells
by: Yifat Koren Carmi, et al.
Published: (2024-06-01)

The SP1-12LOX axis promotes chemoresistance and metastasis of ovarian cancer
by: Qi Zhang, et al.
Published: (2020-05-01)

CHTOP in Chemoresistant Epithelial Ovarian Cancer: A Novel and Potential Therapeutic Target
by: Xiaojie Feng, et al.
Published: (2019-06-01)

Recent advances in the role of long non-coding RNAs in ovarian cancer chemoresistance
by: Shanshan Dong, et al.
Published: (2026-02-01)

MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis
by: Laura Zanotti, et al.
Published: (2017-05-01)

The influence of tumor microenvironment immune in ovarian cancer ascites
by: Diana Nunes, et al.
Published: (2022-04-01)

RAD6 promotes chemoresistance in ovarian cancer
by: David W. Clark, et al.
Published: (2018-01-01)

Long noncoding RNAs as therapeutic targets to overcome chemoresistance in ovarian cancer
by: Linjiao Chen, et al.
Published: (2022-08-01)

Thymidine kinase as a biomarker of chemoresistance in epithelial ovarian cancer using the KELIM model
by: David Lukanović, et al.
Published: (2026-05-01)

Modeling of senescence-related chemoresistance in ovarian cancer using data analysis and patient-derived organoids
by: Xintong Cai, et al.
Published: (2024-02-01)

FGF19 promotes cell autophagy and cisplatin chemoresistance by activating MAPK signaling in ovarian cancer
by: Wei Zhu, et al.
Published: (2023-02-01)

MSLN Correlates With Immune Infiltration and Chemoresistance as a Prognostic Biomarker in Ovarian Cancer
by: Yike Li, et al.
Published: (2022-05-01)

Markers of Primary Chemoresistance of Epithelial Ascites Cells in Patients with Ovarian Cancer Guidelines for Practitioners
by: D. R. Dolgova, et al.
Published: (2020-05-01)

TFEB Regulates ATP7B Expression to Promote Platinum Chemoresistance in Human Ovarian Cancer Cells
by: Raffaella Petruzzelli, et al.
Published: (2022-01-01)

PINK1-PTEN axis promotes metastasis and chemoresistance in ovarian cancer via non-canonical pathway
by: Fang Zheng, et al.
Published: (2023-11-01)

LAMA3 DNA methylation and transcriptome changes associated with chemotherapy resistance in ovarian cancer
by: Li-yuan Feng, et al.
Published: (2021-05-01)

Involvement of small extracellular vesicle-derived TIE-1 in the chemoresistance of ovarian cancer cells
by: Tomoka Misawa, et al.
Published: (2021-01-01)

FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients
by: Renata A. Tassi, et al.
Published: (2017-05-01)